SCHEMBL7968031

SCHEMBL7968031

COc1ccc2cc(OC[C@@H]3CO3)ccc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.61
TP53 P04637 3/20 0.61
TSHR P16473 3/20 0.61
HIF1A Q16665 2/20 0.61
CYP3A4 P08684 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
PKM P14618 2/20 0.59
MAPT P10636 2/20 0.54
HPGD P15428 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
CYP1A2 P05177 2/20 0.54
PPARG P37231 1/20 0.54
TDP1 Q9NUW8 1/20 0.53
LMNA P02545 1/20 0.50
GAA P10253 1/20 0.50
PTPN1 P18031 1/20 0.46
CYP2A6 P11509 1/20 0.46
GLA P06280 1/20 0.45
FGFR1 P11362 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7968034 1.00 ALDH1A1 (0.61) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL7968040 1.00 ALDH1A1 (0.61) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL7977364 0.97 ALDH1A1 (0.57) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL1715242 0.91 ALDH1A1 (0.71) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL7793951 0.87 ALDH1A1 (0.67) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL18125579 0.87 ALDH1A1 (0.67) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL12441429 0.87 ALDH1A1 (0.67) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL29366782 0.87 ALDH1A1 (0.67) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL7962113 0.86 ALDH1A1 (0.83) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL7962118 0.86 ALDH1A1 (0.83) ALDH1A1TP53TSHRHIF1ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed